Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance.
- NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_assertion description "[These results suggest that efatutazone inhibits cell motility by antagonizing the TGF-?/Smad2 pathway and effectively prevents metastasis in NSCLC patients with acquired resistance to EGFR-TKI regardless of the resistance mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance.
- NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_assertion evidence source_evidence_literature NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance.
- NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_assertion SIO_000772 24698130 NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance.
- NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_assertion wasDerivedFrom befree-2016 NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance.
- NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_assertion wasGeneratedBy ECO_0000203 NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1169935.RAsb7hQvzNHRWhMssaBJT10nUhHmvwoqvTIxq7YW9uIvE130_provenance.